In contrast, in RA patients, the principal source of RANKL is CD4+CD28- T cells, and in this setting, RANKL was shown to exert both a positive effect on osteoclastogenesis and detrimental effect on the development of osteoblasts [16,17]. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.